| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,337 | 1,411 | 13:51 | |
| 1,337 | 1,411 | 11:24 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07:46 | REGION GROUP: Becoming a substantial holder | - | ASX | ||
| 06:52 | REGION GROUP: Ceasing to be a substantial holder from MUFG | - | ASX | ||
| Di | REGION GROUP: Ceasing to be a substantial holder | - | ASX | ||
| Mo | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| So | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| Do | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| REGION GROUP Aktie jetzt für 0€ handeln | |||||
| 02.12. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 01.12. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 30.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 27.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 26.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 25.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 24.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 23.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 21.11. | REGION GROUP: Change of Director's Interest Notice | - | ASX | ||
| 21.11. | REGION GROUP: Change of Director's Interest Notice | - | ASX | ||
| 20.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 19.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 18.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX | ||
| 17.11. | REGION GROUP: Update - Notification of buy-back - RGN | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 22,650 | -5,82 % | Formycon: Partnerschaft mit MS Pharma für Keytruda-Biosimilar | Formycon hat mit MS Pharma eine exklusive Lizenz- und Liefervereinbarung für den Biosimilar-Kandidaten FYB206 abgeschlossen, der auf das Blockbuster-Medikament Keytruda (Pembrolizumab) abzielt. Die... ► Artikel lesen | |
| GAUZY | 1,370 | 0,00 % | Gauzy Ltd. - 6-K, Report of foreign issuer | ||
| NVE | 60,50 | +0,83 % | Dividendenbekanntmachungen (03.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADECOAGRO SA LU0584671464 0,1748 USD 0,1515 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,026 EUR AON PLC IE00BLP1HW54 0... ► Artikel lesen | |
| VEECO INSTRUMENTS | 27,600 | -0,72 % | Veeco Instruments Inc.: Veeco Reports Third Quarter 2025 Financial Results | Third Quarter 2025 Highlights: Revenue of $165.9 million, compared with $184.8 million in the same period last yearGAAP net income of $10.6 million, or $0.17 per diluted share, compared with $22.0... ► Artikel lesen | |
| NANOFORM FINLAND | 0,965 | +2,77 % | Nanoform Finland Oyj: Nanoform Q3 report: Momentum in kernels continues, commercial cGMP manufacturing license received, first near-term target for 2026 set | Nanoform Finland Plc | Company Release | November 12, 2025 at 08:10:00 EET
Our product kernels see good momentum. Nanoenzalutamide progresses with the fed arm of the pivotal human study. Licensing and... ► Artikel lesen | |
| KOPIN | 2,296 | -2,05 % | Kopin appoints new leadership to drive microdisplay technology roadmap | ||
| ONTO INNOVATION | 139,00 | -0,71 % | Onto Innovation Inc. (ONTO): A Bull Case Theory | ||
| SOLESENCE | 2,080 | +5,58 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| DOTZ NANO | 0,027 | -5,26 % | DOTZ NANO LIMITED: Dotz to Present at Small Cap Growth Investor Conference | ||
| FENDX TECHNOLOGIES | 0,378 | +13,17 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | |
| INSPLORION | 0,000 | 0,00 % | Insplorion AB: Quarterly report Q3 2025 | July - September
Outcome July - SeptemberNet sales amounted to 926 (490) kSEKProfit after financial items amounted to -3,133 (-3,459) kSEKEarnings per share before and after dilution: SEK -0,04 (-0... ► Artikel lesen | |
| ACACIA RESEARCH | 3,160 | -3,66 % | Acacia Research Non-GAAP EPS of -$0.01 beats by $0.13, revenue of $59.4M beats by $21.4M | ||
| ADVANCE ZINCTEK | 0,530 | 0,00 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
| LAMPETIA | 0,068 | +4,62 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOFOCUS | 1,810 | 0,00 % | HV-Termine: Hauptversammlungen bei bioXXmed, Borussia Dortmund, CureVac, elexxion, Nanofocus, NSI Asset, OTRS | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen |